| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,979 |
23,483 |
$1.80M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,217 |
10,288 |
$1.14M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,003 |
5,617 |
$558K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,651 |
5,135 |
$555K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,403 |
3,286 |
$352K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,915 |
1,669 |
$157K |
| 90723 |
|
3,125 |
2,038 |
$133K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,276 |
10,515 |
$67K |
| 90633 |
|
1,383 |
914 |
$53K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,341 |
2,382 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,864 |
2,989 |
$43K |
| 90686 |
|
2,993 |
2,689 |
$34K |
| 90461 |
|
4,880 |
2,402 |
$23K |
| 90651 |
|
375 |
343 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
317 |
308 |
$17K |
| 85018 |
|
2,852 |
2,228 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,930 |
2,971 |
$11K |
| 99000 |
|
4,803 |
4,006 |
$11K |
| 90648 |
|
4,318 |
2,783 |
$10K |
| 99188 |
|
1,940 |
1,358 |
$8K |
| 99215 |
Prolong outpt/office vis |
52 |
50 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,145 |
2,708 |
$6K |
| 90734 |
|
263 |
213 |
$6K |
| 96127 |
|
2,384 |
2,139 |
$6K |
| 90700 |
|
88 |
88 |
$6K |
| 99177 |
|
6,127 |
4,358 |
$6K |
| 92551 |
|
2,814 |
2,119 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
76 |
43 |
$4K |
| 99051 |
|
1,411 |
1,095 |
$4K |
| 90670 |
|
5,044 |
3,384 |
$4K |
| 90696 |
|
173 |
74 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
348 |
234 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
723 |
627 |
$2K |
| 80061 |
Lipid panel |
243 |
240 |
$2K |
| 96161 |
|
1,422 |
620 |
$2K |
| 90707 |
|
1,036 |
630 |
$1K |
| 81002 |
|
521 |
446 |
$1K |
| 90620 |
|
46 |
45 |
$1K |
| 99173 |
|
1,064 |
789 |
$940.84 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
14 |
12 |
$789.59 |
| 36416 |
|
7,283 |
5,506 |
$701.41 |
| 0071A |
|
22 |
19 |
$684.80 |
| 90680 |
|
2,429 |
1,468 |
$523.70 |
| 90647 |
|
278 |
251 |
$397.22 |
| 90716 |
|
1,074 |
647 |
$337.69 |
| 83655 |
|
827 |
637 |
$323.93 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
14 |
$66.24 |
| 69210 |
|
15 |
12 |
$63.82 |
| 90685 |
|
64 |
44 |
$46.01 |
| 90715 |
|
40 |
40 |
$24.01 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
100 |
96 |
$10.00 |
| 87070 |
|
162 |
158 |
$6.89 |
| 91307 |
|
71 |
60 |
$0.26 |
| 90681 |
|
31 |
25 |
$0.00 |
| D0191 |
|
24 |
12 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$0.00 |